American Equity Investment Life Holding Quarterly Income Statements Chart
Quarterly
|
Annual
American Equity Investment Life Holding Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2006-12-31 | 2005-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net premiums | 752,000,000 | 889,000,000 | 2,482,000,000 | 888,000,000 | ||||||||||||||||||||||
| other policy revenue | 172,000,000 | 149,000,000 | 153,000,000 | 208,000,000 | ||||||||||||||||||||||
| net investment income | 1,160,000,000 | 1,275,000,000 | 1,232,000,000 | 1,024,000,000 | 554,739,000 | 582,176,000 | 586,614,000 | 542,685,000 | 561,323,000 | 537,995,000 | 609,737,000 | 592,308,000 | 567,423,000 | 514,599,000 | 526,366,000 | 499,320,000 | 497,190,000 | 521,725,000 | 543,331,000 | 543,704,000 | 573,318,000 | 588,217,000 | 590,412,000 | 570,568,000 | ||
| investment related gains | 73,000,000 | -4,000,000 | -40,000,000 | -128,000,000 | ||||||||||||||||||||||
| other income | 29,000,000 | 30,000,000 | 33,000,000 | 12,000,000 | ||||||||||||||||||||||
| total revenues | 2,186,000,000 | 2,339,000,000 | 3,714,000,000 | 2,004,000,000 | 989,963,000 | 1,055,131,000 | 266,652,000 | 851,639,000 | 662,548,000 | 654,454,000 | 491,853,000 | 121,395,000 | 147,799,000 | 1,109,261,000 | 542,563,000 | 1,075,440,000 | 962,207,000 | 1,029,699,000 | 798,705,000 | 919,948,000 | -323,703,000 | 1,113,835,000 | 643,396,000 | 706,394,000 | ||
| yoy | 120.82% | 121.68% | 1292.83% | 135.31% | 49.42% | 61.22% | -45.79% | 601.54% | 348.28% | -41.00% | -9.35% | -88.71% | -84.64% | 7.73% | -32.07% | 16.90% | -397.25% | -7.55% | 24.14% | 30.23% | ||||||
| qoq | -6.54% | -37.02% | 85.33% | 102.43% | -6.18% | 295.70% | -68.69% | 28.54% | 1.24% | 33.06% | 305.17% | -17.86% | -86.68% | 104.45% | -49.55% | 11.77% | -6.55% | 28.92% | -13.18% | -384.20% | -129.06% | 73.12% | -8.92% | |||
| policyholder benefits and claims incurred | 828,000,000 | 888,000,000 | 2,399,000,000 | 846,000,000 | ||||||||||||||||||||||
| interest sensitive contract benefits | 485,000,000 | 512,000,000 | 677,000,000 | 523,000,000 | ||||||||||||||||||||||
| amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | 332,000,000 | 318,000,000 | 290,000,000 | 289,000,000 | ||||||||||||||||||||||
| change in fair value of insurance-related derivatives and embedded derivatives | 131,000,000 | 199,000,000 | -440,000,000 | 344,000,000 | ||||||||||||||||||||||
| change in fair value of market risk benefits | -47,000,000 | 361,000,000 | -295,000,000 | 134,000,000 | ||||||||||||||||||||||
| operating expenses | 216,000,000 | 275,000,000 | 214,000,000 | 228,000,000 | ||||||||||||||||||||||
| interest expense | 49,000,000 | 44,000,000 | 51,000,000 | 49,000,000 | ||||||||||||||||||||||
| total benefits and expenses | 1,994,000,000 | 2,597,000,000 | 2,896,000,000 | 2,413,000,000 | 554,072,000 | 1,626,783,000 | -343,153,000 | 400,841,000 | 854,447,000 | 693,030,000 | 93,038,000 | -343,508,000 | -573,516,000 | 994,869,000 | 345,001,000 | 1,145,866,000 | 600,988,000 | 1,019,764,000 | -53,049,000 | 1,235,851,000 | -593,878,000 | 833,008,000 | 592,391,000 | 683,198,000 | ||
| net income before income taxes | 192,000,000 | -258,000,000 | 818,000,000 | -409,000,000 | ||||||||||||||||||||||
| income tax benefit | 38,000,000 | -55,000,000 | 167,000,000 | -77,000,000 | 93,246,000 | -36,008,000 | 104,327,000 | -15,732,000 | -68,474,000 | 27,228,000 | 4,606,000 | |||||||||||||||
| net income | 154,000,000 | -203,000,000 | 651,000,000 | -332,000,000 | 342,645,000 | -463,450,000 | 476,114,000 | 355,146,000 | -155,891,000 | -18,098,000 | 312,601,000 | 360,576,000 | 566,223,000 | 93,137,000 | 152,865,000 | -54,694,000 | 282,684,000 | 8,742,000 | 667,200,000 | -247,429,000 | 242,947,000 | 220,150,000 | 37,360,000 | 18,590,000 | ||
| yoy | -55.06% | -56.20% | 36.73% | -193.48% | -319.80% | 2460.78% | 52.31% | -1.51% | -127.53% | -119.43% | 104.49% | -759.26% | 100.30% | 965.40% | -77.09% | -77.90% | 16.36% | -96.03% | 1685.87% | -1430.98% | ||||||
| qoq | -175.86% | -131.18% | -296.08% | -196.89% | -173.93% | -197.34% | 34.06% | -327.82% | 761.37% | -105.79% | -13.31% | -36.32% | 507.95% | -39.07% | -379.49% | -119.35% | 3133.63% | -98.69% | -369.65% | -201.84% | 10.36% | 489.27% | 100.97% | |||
| net income margin % | 7.04% | -8.68% | 17.53% | -16.57% | 34.61% | -43.92% | 178.55% | 41.70% | -23.53% | -2.77% | 63.56% | 297.03% | 383.10% | 8.40% | 28.17% | -5.09% | 29.38% | 0.85% | 83.54% | -26.90% | -75.05% | 19.77% | 5.81% | 2.63% | ||
| less: net income attributable to noncontrolling interests | 2,000,000 | 3,000,000 | 2,000,000 | -44,000,000 | ||||||||||||||||||||||
| net income attributable to american national group inc. stockholders | 152,000,000 | -206,000,000 | 649,000,000 | -288,000,000 | ||||||||||||||||||||||
| less: preferred stock dividends and redemption | 11,000,000 | 30,000,000 | ||||||||||||||||||||||||
| net income attributable to american national group inc. common stockholder | 141,000,000 | -236,000,000 | 638,000,000 | -299,000,000 | ||||||||||||||||||||||
| less: preferred stock dividends | 11,000,000 | 11,000,000 | 10,919,000 | 10,919,000 | 10,918,000 | 10,919,000 | 10,919,000 | 10,919,000 | 10,918,000 | 10,919,000 | 10,919,000 | 10,919,000 | 10,918,000 | 10,919,000 | 10,919,000 | 15,004,000 | 5,950,000 | 5,950,000 | 6,611,000 | |||||||
| revenues: | ||||||||||||||||||||||||||
| premiums and other considerations | 640,000 | 2,657,000 | 2,657,000 | 2,516,000 | 4,137,000 | 2,991,000 | 2,839,000 | 3,831,000 | 10,078,000 | 14,553,000 | 15,841,000 | 14,595,000 | 13,213,000 | 10,279,000 | 10,407,000 | 11,032,000 | 7,664,000 | 8,846,000 | 5,152,000 | 4,126,000 | ||||||
| annuity product charges | 95,613,000 | 96,947,000 | 84,316,000 | 71,642,000 | 62,591,000 | 61,666,000 | 60,819,000 | 55,514,000 | 52,355,000 | 60,310,000 | 58,480,000 | 63,759,000 | 60,082,000 | 65,963,000 | 62,277,000 | 63,438,000 | 59,549,000 | 62,722,000 | 63,647,000 | 60,700,000 | ||||||
| change in fair value of derivatives | 409,767,000 | 353,443,000 | -383,026,000 | 242,739,000 | 45,890,000 | 22,243,000 | -176,671,000 | -506,181,000 | -477,519,000 | 522,251,000 | -70,701,000 | 500,880,000 | 396,305,000 | 443,867,000 | 205,011,000 | 327,662,000 | -941,874,000 | 466,434,000 | -20,042,000 | 76,045,000 | ||||||
| net realized losses on investments | -94,050,000 | -2,065,000 | -44,672,000 | -24,679,000 | -27,787,000 | -33,272,000 | -13,127,000 | -3,114,000 | -4,583,000 | |||||||||||||||||
| other revenue | 23,254,000 | 21,973,000 | 20,763,000 | 16,736,000 | 16,394,000 | 15,148,000 | 10,989,000 | 9,195,000 | 8,589,000 | 8,026,000 | 7,644,000 | |||||||||||||||
| benefits and expenses: | ||||||||||||||||||||||||||
| insurance policy benefits and change in future policy benefits | 4,238,000 | 3,161,000 | 2,193,000 | 5,125,000 | 7,208,000 | 5,663,000 | 5,707,000 | 7,091,000 | 12,638,000 | 16,975,000 | 18,756,000 | 15,828,000 | 16,424,000 | 13,066,000 | 13,273,000 | 13,331,000 | 10,072,000 | 11,553,000 | 7,627,000 | 6,939,000 | ||||||
| interest sensitive and index product benefits | 304,220,000 | 193,439,000 | 193,686,000 | 122,387,000 | 57,911,000 | 160,243,000 | 121,890,000 | 234,855,000 | 372,662,000 | 574,816,000 | 817,014,000 | 812,981,000 | 476,595,000 | 325,912,000 | 576,147,000 | 240,992,000 | 400,219,000 | 399,514,000 | 500,285,000 | 251,103,000 | ||||||
| market risk benefits (gains) losses | -138,770,000 | 241,998,000 | -296,114,000 | -144,124,000 | 183,694,000 | |||||||||||||||||||||
| amortization of deferred sales inducements | 54,214,000 | 50,346,000 | 48,354,000 | 46,951,000 | 46,601,000 | 46,773,000 | 127,784,000 | 90,446,000 | 143,545,000 | 59,409,000 | -17,172,000 | -12,520,000 | 122,975,000 | 22,768,000 | 416,983,000 | -75,178,000 | 73,591,000 | 91,260,000 | -55,769,000 | 19,785,000 | ||||||
| change in fair value of embedded derivatives | 162,202,000 | 977,178,000 | -451,806,000 | 213,764,000 | 404,440,000 | 342,409,000 | -415,374,000 | -885,984,000 | -1,393,649,000 | 186,802,000 | -536,404,000 | 273,713,000 | -282,413,000 | 568,836,000 | -1,732,497,000 | 1,126,935,000 | -1,250,061,000 | 147,879,000 | 212,278,000 | 327,562,000 | ||||||
| interest expense on notes and loan payable | 11,581,000 | 11,642,000 | 12,003,000 | 11,227,000 | 11,018,000 | |||||||||||||||||||||
| interest expense on subordinated debentures | 1,342,000 | 1,341,000 | 1,340,000 | 1,338,000 | 1,336,000 | 1,335,000 | 1,333,000 | 1,346,000 | 1,317,000 | 1,330,000 | 1,342,000 | 1,326,000 | 1,326,000 | 1,325,000 | 1,323,000 | 1,321,000 | 1,588,000 | 3,651,000 | 3,968,000 | 4,057,000 | ||||||
| amortization of deferred policy acquisition costs | 77,337,000 | 72,428,000 | 70,561,000 | 68,476,000 | 68,235,000 | 64,338,000 | 183,182,000 | 142,354,000 | 225,426,000 | 82,999,000 | -1,588,000 | -16,906,000 | 203,823,000 | 26,145,000 | 622,596,000 | -119,889,000 | 120,702,000 | 133,573,000 | -120,934,000 | 29,946,000 | ||||||
| other operating costs and expenses | 77,708,000 | 75,250,000 | 76,630,000 | 75,697,000 | 74,004,000 | 62,041,000 | 59,532,000 | 59,923,000 | 58,120,000 | 66,279,000 | 56,518,000 | 65,050,000 | 55,865,000 | 55,321,000 | 42,738,000 | 41,951,000 | 43,626,000 | 39,194,000 | 38,554,000 | 37,426,000 | ||||||
| income before income taxes | 435,891,000 | -571,652,000 | 609,805,000 | 450,798,000 | -191,899,000 | -38,576,000 | 398,815,000 | 464,903,000 | 721,315,000 | 114,392,000 | 197,562,000 | -70,426,000 | 361,219,000 | 9,935,000 | 851,754,000 | -315,903,000 | 270,175,000 | 280,827,000 | 51,005,000 | 23,196,000 | ||||||
| less: net income available to noncontrolling interests | -353,000 | 1,545,000 | -42,000 | -217,000 | 103,000 | 361,000 | 1,000 | -4,000 | ||||||||||||||||||
| net income available to american equity investment life holding company stockholders | 342,998,000 | -464,995,000 | 476,156,000 | 355,363,000 | -155,994,000 | -18,459,000 | 312,600,000 | 360,580,000 | 566,223,000 | |||||||||||||||||
| net income available to american equity investment life holding company common stockholders | 332,079,000 | -475,914,000 | 465,238,000 | 344,444,000 | -166,913,000 | -29,378,000 | 301,682,000 | 349,661,000 | 555,304,000 | |||||||||||||||||
| earnings per common share | 4,200 | -5,960 | 5,960 | 4,430 | -2,000 | -70 | 3,440 | 3,780 | 5,730 | 890 | 1,530 | -690 | 2,840 | -90 | 7,200 | -2,760 | 2,580 | 2,420 | 410 | 200 | ||||||
| earnings per common share - assuming dilution | 4,130 | -5,860 | 5,820 | 4,360 | -2,000 | -80 | 3,410 | 3,740 | 5,670 | 880 | 1,530 | -690 | 2,820 | -100 | 7,170 | -2,760 | 2,570 | 2,400 | 410 | 200 | ||||||
| weighted-average common shares outstanding | ||||||||||||||||||||||||||
| income tax expense | -108,202,000 | 133,691,000 | 95,652,000 | -20,478,000 | 86,214,000 | 155,092,000 | 21,255,000 | 44,697,000 | 78,535,000 | 1,193,000 | 184,554,000 | 60,677,000 | 13,645,000 | |||||||||||||
| net realized gains on investments | -15,564,750 | -15,860,000 | -10,478,000 | 4,933,000 | -12,135,000 | -22,321,000 | -25,888,000 | |||||||||||||||||||
| interest expense on notes payable | 5,467,500 | 8,984,000 | 6,461,000 | 6,425,000 | 6,259,000 | 6,535,000 | 6,394,000 | 6,393,000 | 6,391,000 | 6,388,000 | 6,388,000 | 6,385,000 | 4,785,250 | 6,382,000 | 6,380,000 | |||||||||||
| loss on extinguishment of debt | -2,024,000 | |||||||||||||||||||||||||
| net income available to common stockholders | 82,218,000 | 141,947,000 | -65,613,000 | 271,765,000 | -6,262,000 | 661,250,000 | -253,379,000 | 236,336,000 | ||||||||||||||||||
| other than temporary impairment (otti) losses on investments: | ||||||||||||||||||||||||||
| total otti losses | -17,412,000 | -101,000 | -998,000 | |||||||||||||||||||||||
| portion of otti losses recognized from other comprehensive income | -215,000 | |||||||||||||||||||||||||
| net otti losses recognized in operations | -17,412,000 | -101,000 | -1,213,000 | |||||||||||||||||||||||
| net realized gains on investments, excluding credit losses on fixed maturity securities, available for sale | 11,035,000 | |||||||||||||||||||||||||
| credit losses on fixed maturity securities, available for sale | -31,371,000 | |||||||||||||||||||||||||
| net realized gains on investments, excluding other than temporary impairment ("otti") losses | -16,750 | 4,328,000 | ||||||||||||||||||||||||
| otti losses on investments: | ||||||||||||||||||||||||||
| net realized losses on investments, excluding other than temporary impairment ("otti") losses | -3,832,000 |
We provide you with 20 years income statements for American Equity Investment Life Holding stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of American Equity Investment Life Holding stock. Explore the full financial landscape of American Equity Investment Life Holding stock with our expertly curated income statements.
The information provided in this report about American Equity Investment Life Holding stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.